A Phase 1 Study To Evaluate The Pharmacokinetics (PK), Safety, And Bioavailability Of A Modified-Release (MR) Formulation Of Tofacitinib In Healthy Volunteers

Femme et Homme

| Pays :
Singapore
| Organes :
| Spécialités :

Extrait

This study will explore the drug behavior and safety following single doses of tofacitinib modified-release (MR) 11 mg and MR 22 mg in healthy volunteers.

Critère d'inclusion

Healthy

Liens

ictrp
nct